Acute nephritic syndrome as the sentinel presentation of class III A lupus nephritis in a young patient

Authors

  • Anjitha S. Department of Paediatrics Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India
  • Carol Sara Cherian Department of Paediatrics Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India
  • Reena Thomas Department of Nephrology, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20261919

Keywords:

Systemic lupus erythematosus, ISN/RPS class III, Full house immunofluorescence, Renal biopsy, Nephritic syndrome

Abstract

Lupus nephritis (LN) is one of the most serious manifestations of Systemic lupus erythematosus (SLE), occurring in 50-75% of children with SLE, with over 90% developing renal involvement within two years of diagnosis. We describe a diagnostically challenging case of a 12-year-old girl presenting with nephritic syndrome, in whom further evaluation revealed an underlying diagnosis of Systemic lupus erythematosus (SLE). Investigations revealed hypocomplementemia (C3 21.0 mg/dl, C4 1.6 mg/dl), positive antinuclear antibody (ANA IF titre 1:80, ANA ELISA 7.9), strongly positive anti-double-stranded DNA (anti-dsDNA +++), significant proteinuria on 24-hour collection (888 mg/day), and microscopic haematuria. She fulfilled three of eleven American college of rheumatology (ACR) 1997 criteria for SLE. Light microscopy demonstrated focal segmental endocapillary hypercellularity with focal mesangial prominence. Renal biopsy confirmed focal proliferative lupus nephritis (ISN/RPS Class IIIA) with a NIH activity index of 3/24 and a characteristic ‘full house’ immunofluorescence pattern comprising deposits of IgG (2+), IgA (3+), IgM (1+/2+), C3 (1+/2+), C1q (3+), kappa (1+/2+), and lambda (2+). This case underscores the importance of maintaining a high index of suspicion for SLE in children with nephritic features and hypocomplementemia. Renal biopsy is essential for definitive classification and treatment planning even when ACR criteria are not fully met. Early histopathological diagnosis and class-guided immunosuppressive therapy are critical to preventing progression to end-stage renal disease in paediatric lupus nephritis.

References

Sinha R, Raut S. Pediatric lupus nephritis: Management update. World J Nephrol. 2014;3(2):16-23.

Bennett M, Brunner HI. Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am. 2013;39(4):833-53.

Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241-50.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

Bertsias G, Ioannidis JPA, Boletis JN, Bombardieri S. EULAR recommendations for the management of systemic lupus erythematosus: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008;67(2):195-205.

Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum. 2012;41(5):623-35.

Hagelberg S, Lee Y, Bargman JM, Silverman ED. Long-term follow-up of childhood lupus nephritis. J Rheumatol. 2002;29(12):2635-42.

Marks SD, Tullus K. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis. Acta Paediatr. 2010;99(7):967-74.

Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556-62.

Appel GB, Contreras G, Dooley MA, Bruce IN, Ginzler EM, Isenberg D, et al. Aspreva Lupus Management Study Group. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009;20(5):1103-12.

Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797-808.

Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2(2):139-274.

Moorthy LN, Peterson MG, Hassett AL, Lehman TJ. Pediatric-onset systemic lupus erythematosus: a review. Pediatr Ann. 2012;41(8):e113-21.

Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-86.

Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier. 2020;1180-9.

Downloads

Published

2026-06-22

How to Cite

S., A., Cherian, C. S., & Thomas, R. (2026). Acute nephritic syndrome as the sentinel presentation of class III A lupus nephritis in a young patient. International Journal of Contemporary Pediatrics, 13(7), 1229–1232. https://doi.org/10.18203/2349-3291.ijcp20261919

Issue

Section

Case Reports